Companies in the biotechnology sector developing innovative solutions and technologies.
Explore 5,823 recently funded biotechnology companies with verified founder contact information and fundraising data.
The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.
Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.
SeaStock develops global marine science solutions for producing and extracting substances produced from seaweed and algae.
Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Cultimar Technologies engages in harvesting the full potential of aquaculture.
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Hydrosome Labs develops a patent-pending proprietary technology to create a medium for hydration and a delivery vehicle for solutes.
Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Aurora is an early-stage start-up company focused on bringing advanced solutions to the spinal implant market.
Sisu is a medical device company that designs and commercializes medical devices with and for emerging markets.
Mongoose Bio is a biotechnology company thatc offers precision T-cell bases cancer therapies.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
Kihealth is launching the world's first blood test capable of identifying diabetes risk before symptoms emerge.
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Entoinnov uses an insect-based bioprocess that converts agricultural by-products into superfood ingredients for humans and animals.
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures.
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Aurora Analytica advances global health by optimizing the clinical trial lifecycle with cutting-edge technology and AI.
The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 5,823 biotechnology companies tracked in the VCBacked database.
Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked